Common surgical drug may hold key to stopping lung Cancer's return
NCT ID NCT07347977
Summary
This study is testing if giving the numbing drug lidocaine during and right after lung cancer surgery can help prevent the cancer from coming back or spreading. About 1,400 patients having minimally invasive surgery will be randomly assigned to receive either lidocaine or a placebo (saltwater) infusion. Researchers will follow patients for three years after surgery to see if the lidocaine group has a longer period without the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The first affiliated hospital of Ningbo University
Ningbo, Zhejiang, 315000, China
Conditions
Explore the condition pages connected to this study.